February 20, 2012

AparnaBio and InteRNA Technologies have entered into a research collaboration to investigate development of a cancer therapeutic by combining AparnaBio’s ligand targeted NanoElectroPlex(TM) technology with InteRNA’s therapeutic miRNA sequences.